References

Aggarwal, R., U. Chaudhary and K. Bala, 2008. Detection of extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Ind. Pathol. Microbiol., 51: 222-224.
PubMed  |  

Aibinu, I., T. Nwanneka and T. Odugbemi, 2007. Occurrence of ESBL and MBL in clinical isolates of Pseudomonas aeruginosa from Lagos, Nigeria. J. Am. Sci., 3: 81-85.
Direct Link  |  

Aktas, Z., L. Poirel, M. Salcioglu, P.E. Ozcan, K. Midilli, C. Bal, O. Ang and P. Nordmann, 2005. PER-1-and OXA-10-like beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates from intensive care unit patients in Istanbul, Turkey. Clin Microbiol Infect., 11: 193-198.
PubMed  |  

Al Naiemi, N., B. Duim and A. Bart, 2006. A CTX-M extended-spectrum beta-lactamase in Pseudomonas aeruginosa and Stenoprophomonas maltophilia. J. Med. Microbiol., 55: 1607-1608.
PubMed  |  

Bagge, N., O. Clofu, M. Hentzer, J.I. Campbell, M. Givskov and N. Holby, 2002. Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in Amp D. Antimicrob. Agents Chemother., 46: 3406-3411.
PubMed  |  

CLSI, 2007. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement. Clinical and Laboratory Standards Institute, Wayne, PA., USA., ISBN-13: 9781562386252, Pages: 177.

Celenza, G., C. Pellegrini, M. Caccamo, B. Segatore, G. Amicosante and M. Perilli, 2006. Spread of bla CTX-M-type and bla PER-2 beta-lactamase genes in clinical isolates from BoSpread of bla CTX-M-type and bla PER-2 β-lactamase genes in clinical isolates from Bolivian hospitals.livian hospitals. J. Antimicrob. Chemother., 57: 975-978.
PubMed  |  Direct Link  |  

Giamarellou H., 2002. Prescribing guidelines for severe Pseudomonas infections. J. Antimicrob. Chemother., 49: 229-233.
CrossRef  |  Direct Link  |  

Hauser, A.R. and P. Sriram, 2005. Severe Pseudomonas aeruginosa infections: Tackling the conundrum of drug resistance. Postgrad Med., 117: 41-48.
Direct Link  |  

Jarlier, V., M. Nicolas, G. Fournier and A. Philippon, 1988. Extended-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 10: 867-878.
PubMed  |  

Lim, K.T., R.M. Yasin, C.C. Yeo, S.D. Puthucheary and G. Balan et al., 2009. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia. J. Microbiol. Immunol. Infect., 42: 197-209.
PubMed  |  

Livermore, D.M., 2001. Of Pseudomonas, porins, pumps and carbapenems. J. Antimicrob. Chemother., 47: 247-250.
Direct Link  |  

McGowan Jr, J.E., 2006. Resistance in non-fermenting Gram- negative bacteria: Multidrug resistance to the maximum. Am. J. Infect. Control., 34: 529-537.
PubMed  |  

Mesaros, N., P. Nordmann, P. Plesiat, M. Roussel-Delvallez and J. van Eldere et al., 2007. Pseudomonas aeruginosa: Resistance and therapeutic options at the turn of the new millennium. Clin. Microbiol. Infect., 13: 560-578.
CrossRef  |  Direct Link  |  

Nathisuwan, S., D.S. Burgess and J.S. Lewis, 2001. Extended spectrum beta-lactamases, epidemiology, detection and treatment. Pharmacotherapy, 21: 920-928.
Direct Link  |  

Nordmann, P. and M. Gilbert, 1998. Extended-spectrum β-lactamases in Pseudomonas aeruginosa.. J. Antimicrob. Chemother., 42: 128-131.

Okesola, A.O. and A.A. Oni, 2011. Susceptibility profile of clinical isolates of Pseudomonas aeruginosa to recommended antipseudomonal antibiotics in Ibadan, Nigeria. Ann. Trop. Path., 2: 37-43.

Pollack, M., 2000. Pseudomonas aeruginosa. In: Principles and Practice of Infectious Diseases, Mandell, G.L., J.E. Bennett and R. Dolin (Eds.). 5th Edn. Churchill Livingstone, Edinburgh, Scotland, pp: 2310-2335.

Shahid, M., Malik A. Sheeba, 2003. Multidrug resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC β-lactamases isolated from hospitalized burn patients in tertiary care hospital of North India. FEMS Microbiol. Lett., 228: 181-186.
PubMed  |  

Tavajjohi, Z., R. Moniri and A Khorshidi, 2011. Detection and characterization of multidrug resistance and extended-spectrum-beta-lactamase-producing (ESBL_S) Pseudomonas aeruginosa isolates in teaching hospital. Afr. J. Microbiol. Res., 20: 3223-3228.
Direct Link  |  

Thomson, K.S., C.C. Saunders and E.S. Moland, 1999. Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among Escherichia coli, Klebsiella spp, Enterobacter spp, Citrobacter freundii and Serratia marcescens. Antimicrob. Agents. Chemother., 43: 1393-1400.
PubMed  |  Direct Link  |  

Woodford, N., J. Zhang, M.E. Kaufmann, S. Yarde and M.M. Tomas et al., 2008. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum β-lactamases in the United Kingdom. J. Antimicrob. Chemother., 62: 1265-1268.
CrossRef  |